These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 17827059

  • 1. Variability of the human immunodeficiency virus type 1 polymerase gene from treatment naïve patients in Accra, Ghana.
    Sagoe KW, Dwidar M, Lartey M, Boamah I, Agyei AA, Hayford AA, Mingle JA, Arens MQ.
    J Clin Virol; 2007 Oct; 40(2):163-7. PubMed ID: 17827059
    [Abstract] [Full Text] [Related]

  • 2. High incidence of non-B and recombinant HIV-1 strains in newly diagnosed patients in Galicia, Spain: study of genotypic resistance.
    Pérez-Alvarez L, Carmona R, Muñoz M, Delgado E, Thomson MM, Contreras G, Pedreira JD, Rodríguez Real R, Vázquez de Parga E, Medrano L, Taboada JA, Nájera R, Spanish Group for Antiretroviral Resistance Studies in Galicia.
    Antivir Ther; 2003 Aug; 8(4):355-60. PubMed ID: 14518705
    [Abstract] [Full Text] [Related]

  • 3. Subtype analysis and mutations to antiviral drugs in HIV-1-infected patients from Mozambique before initiation of antiretroviral therapy: results from the DREAM programme.
    Bellocchi MC, Forbici F, Palombi L, Gori C, Coelho E, Svicher V, D'Arrigo R, Emberti-Gialloreti L, Ceffa S, Erba F, Marazzi MC, Silberstein FC, Perno CF.
    J Med Virol; 2005 Aug; 76(4):452-8. PubMed ID: 15977236
    [Abstract] [Full Text] [Related]

  • 4. HIV-1 primary and secondary antiretroviral drug resistance and genetic diversity among pregnant women from central Brazil.
    Cardoso LP, Pereira GA, Viegas AA, Schmaltz LE, Stefani MM.
    J Med Virol; 2010 Mar; 82(3):351-7. PubMed ID: 20087934
    [Abstract] [Full Text] [Related]

  • 5. Polymorphisms and drug resistance analysis of HIV-1 CRF01_AE strains circulating in Fujian Province, China.
    Liu J, Yue J, Wu S, Yan Y.
    Arch Virol; 2007 Mar; 152(10):1799-805. PubMed ID: 17619115
    [Abstract] [Full Text] [Related]

  • 6. Analysis of the diversity of the HIV-1 pol gene and drug resistance associated changes among drug-naïve patients in Burkina Faso.
    Tebit DM, Sangaré L, Tiba F, Saydou Y, Makamtse A, Somlare H, Bado G, Kouldiaty BG, Zabsonre I, Yameogo SL, Sathiandee K, Drabo JY, Kräusslich HG.
    J Med Virol; 2009 Oct; 81(10):1691-701. PubMed ID: 19697403
    [Abstract] [Full Text] [Related]

  • 7. Sustained appearance of drug resistance-associated mutations in HIV-1 CRF01_AE protease and reverse transcriptase derived from protease inhibitor-naive Thai patients.
    Jullaksorn D, Boonchawalit S, Uttiyoung J, Soonthornsata B, Yowang A, Krathong N, Chautrakul S, Ikuta K, Roobsoong A, Kanitvittaya S, Sawanpanyalert P, Kameoka M.
    Southeast Asian J Trop Med Public Health; 2010 Mar; 41(2):347-57. PubMed ID: 20578518
    [Abstract] [Full Text] [Related]

  • 8. HIV-1 pol phylogenetic diversity and antiretroviral resistance mutations in treatment naïve patients from Central West Brazil.
    Cardoso LP, Queiroz BB, Stefani MM.
    J Clin Virol; 2009 Oct; 46(2):134-9. PubMed ID: 19682948
    [Abstract] [Full Text] [Related]

  • 9. Genetic diversity and drug resistance mutations in HIV type 1 from untreated patients in Bamako, Mali.
    Derache A, Traore O, Koita V, Sylla A, Tubiana R, Simon A, Canestri A, Carcelain G, Katlama C, Calvez V, Cisse M, Marcelin AG.
    Antivir Ther; 2007 Oct; 12(1):123-9. PubMed ID: 17503757
    [Abstract] [Full Text] [Related]

  • 10. Human immunodeficiency virus type 1 protease and reverse transcriptase mutation patterns among treatment-naive patients in different stages of infection in Rio de Janeiro, Brazil.
    Varella RB, Ferreira SB, de Castro MB, Zalis MG, Tavares MD.
    J Med Virol; 2007 Aug; 79(8):1033-9. PubMed ID: 17596836
    [Abstract] [Full Text] [Related]

  • 11. Genetic characterization of HIV-1 strains in Togo reveals a high genetic complexity and genotypic drug-resistance mutations in ARV naive patients.
    Yaotsè DA, Nicole V, Roch NF, Mireille PD, Eric D, Martine P.
    Infect Genet Evol; 2009 Jul; 9(4):646-52. PubMed ID: 19460333
    [Abstract] [Full Text] [Related]

  • 12. Characterization of drug-resistance mutations in HIV-1 isolates from non-HAART and HAART treated patients in Burkina Faso.
    Nadembega WM, Giannella S, Simpore J, Ceccherini-Silberstein F, Pietra V, Bertoli A, Pignatelli S, Bellocchi MC, Nikiema JB, Cappelli G, Bere A, Colizzi V, Perno CP, Musumeci S.
    J Med Virol; 2006 Nov; 78(11):1385-91. PubMed ID: 16998878
    [Abstract] [Full Text] [Related]

  • 13. Moderate prevalence of transmitted drug resistance and high HIV-1 genetic diversity in patients from Mato Grosso State, Central Western Brazil.
    Ferreira AS, Cardoso LP, Stefani MM.
    J Med Virol; 2011 Aug; 83(8):1301-7. PubMed ID: 21678433
    [Abstract] [Full Text] [Related]

  • 14. Natural polymorphism in protease and reverse transcriptase genes and in vitro antiretroviral drug susceptibilities of non-B HIV-1 strains from treatment-naive patients.
    Vergne L, Stuyver L, Van Houtte M, Butel C, Delaporte E, Peeters M.
    J Clin Virol; 2006 May; 36(1):43-9. PubMed ID: 16563858
    [Abstract] [Full Text] [Related]

  • 15. Prevalence of antiretroviral drug resistance mutations and HIV-1 non-B subtypes in newly diagnosed drug-naïve patients in Slovenia, 2000-2004.
    Babic DZ, Zelnikar M, Seme K, Vandamme AM, Snoeck J, Tomazic J, Vidmar L, Karner P, Poljak M.
    Virus Res; 2006 Jun; 118(1-2):156-63. PubMed ID: 16417938
    [Abstract] [Full Text] [Related]

  • 16. Analysis of drug resistance-associated mutations in treatment-naïve individuals infected with different genetic forms of HIV-1 circulating in countries of the former Soviet Union.
    Vázquez de Parga E, Rakhmanova A, Pérez-Alvarez L, Vinogradova A, Delgado E, Thomson MM, Casado G, Sierra M, Muñoz M, Carmona R, Vega Y, Contreras G, Medrano L, Osmanov S, Nájera R.
    J Med Virol; 2005 Nov; 77(3):337-44. PubMed ID: 16173024
    [Abstract] [Full Text] [Related]

  • 17. Evolution of genetic diversity and drug resistance mutations in HIV-1 among untreated patients from Mali between 2005 and 2006.
    Derache A, Maiga AI, Traore O, Akonde A, Cisse M, Jarrousse B, Koita V, Diarra B, Carcelain G, Barin F, Pizzocolo C, Pizarro L, Katlama C, Calvez V, Marcelin AG.
    J Antimicrob Chemother; 2008 Sep; 62(3):456-63. PubMed ID: 18556706
    [Abstract] [Full Text] [Related]

  • 18. Absence of genotypic drug resistance and presence of several naturally occurring polymorphisms of human immunodeficiency virus-1 CRF06_cpx in treatment-naive patients in Estonia.
    Avi R, Huik K, Sadam M, Karki T, Krispin T, Ainsalu K, Paap P, Schmidt J, Nikitina N, Lutsar I.
    J Med Virol; 2009 Jun; 81(6):953-8. PubMed ID: 19382254
    [Abstract] [Full Text] [Related]

  • 19. Polymorphisms and resistance mutations in the protease and reverse transcriptase genes of HIV-1 F subtype Romanian strains.
    Paraschiv S, Otelea D, Dinu M, Maxim D, Tinischi M.
    Int J Infect Dis; 2007 Mar; 11(2):123-8. PubMed ID: 16762582
    [Abstract] [Full Text] [Related]

  • 20. Prevalence of the K65R resistance reverse transcriptase mutation in different HIV-1 subtypes in Israel.
    Turner D, Shahar E, Katchman E, Kedem E, Matus N, Katzir M, Hassoun G, Pollack S, Kessner R, Wainberg MA, Avidor B.
    J Med Virol; 2009 Sep; 81(9):1509-12. PubMed ID: 19626612
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.